share_log

博安生物:自願性公告阿柏西普眼內注射溶液(BA9101)在中國完成III期臨床試驗及計劃遞交上市申請

BOAN BIOTECH: VOLUNTARY ANNOUNCEMENTPHASE 3 CLINICAL TRIAL COMPLETED IN CHINA FOR AFLIBERCEPT INTRAVITREOUS INJECTION (BA9101) AND BLA TO BE FILED

Hong Kong Stock Exchange ·  Apr 8 04:31
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more